Log in

Relevant bibliographies by topics / Ticarcilline / Journal articles

To see the other types of publications on this topic, follow the link: Ticarcilline.

Journal articles on the topic 'Ticarcilline'

Author: Grafiati

Published: 4 June 2021

Last updated: 11 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Ticarcilline.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Buxeraud, Jacques, and Alexis Skrzypek. "Ticarpen® - ticarcilline." Actualités Pharmaceutiques 47, no. 474 (2008): 55–57. http://dx.doi.org/10.1016/s0515-3700(08)70224-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Berche, P., and C. Offredo. "Efficacite in vivo de ticarcilline, ticarcilline-acide clavulanique et piperacilline au cours d'une infection experimentale par deux souches de E. cloacae." Médecine et Maladies Infectieuses 18 (September 1988): 59–62. http://dx.doi.org/10.1016/s0399-077x(88)80349-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kabbaj, Hakima, Myriam Seffar, Bouchra Belefquih та ін. "Prevalence of Metallo-β-Lactamases Producing Acinetobacter baumannii in a Moroccan Hospital". ISRN Infectious Diseases 2013 (3 грудня 2013): 1–3. http://dx.doi.org/10.5402/2013/154921.

Full text

Abstract:

Objective. To determine the prevalence of metallo beta-lactamases (MBL) among carbapenem resistant strains of Acinetobacter baumannii in our hospital. Methodology. During a period of 12 months (January–December 2010), 47 isolates of Acinetobacter baumannii were collected from different clinical specimens of in-patients. Antimicrobial susceptibility was determined and interpreted using the disk diffusion method according to the Antibiogram Committee of the French Society for Microbiology guidelines. Imipenem nonsusceptible isolates were further screened for production of MBL. Results. All Acine

APA, Harvard, Vancouver, ISO, and other styles

4

Olivier, Galvez, Mullot Jean-Ulrich, Mullot Hélène, et al. "Étude de stabilité d’un collyre à 6 mg/mL de ticarcilline." Le Pharmacien Hospitalier 42, no. 171 (2007): 171–76. http://dx.doi.org/10.1016/s0768-9179(07)78193-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Miquel, M., D. Blaise, C. Fauchet, and D. Maraninchi. "Infection chez le neutropénique profond. Utilisation de l'association ticarcilline-acide clavulanique." Médecine et Maladies Infectieuses 23 (October 1993): 61–66. http://dx.doi.org/10.1016/s0399-077x(05)80516-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Muhammad Iqbal Khan, Riffat Arbab., Abdullah Khan, et al. "COMMONLY ISOLATED ORGANISM IN DIABETIC FOOT AND ITS ANTIBIOTIC SENSITIVITY, AN EXPERIENCE AT TERTIARY CARE HOSPITAL." Journal of University Medical & Dental College 11, no. 1 (2020): 23–30. http://dx.doi.org/10.37723/jumdc.v11i1.310.

Full text

Abstract:

Abstract BACKGROUND & OBJECTIVE: To determine the commonly isolated organism in ulcers of diabetic foot and its sensitivity to antibiotics. METHODOLOGY: A total of 167 patients of diabetic foot were included in this descriptive Crosssectional study. All the patients were informed and consent was obtained according to ethical criteria approved by the ethical committee. The use of antibiotics in last 72 hours was strictly observed. The samples were obtained under aseptic conditions by applying the swap slightly to the exudate or base of the ulcer and were then carefully transferr

APA, Harvard, Vancouver, ISO, and other styles

7

Brogard, J. M., F. Jehl, J. F. Blickle, M. Dorner, and H. Monteil. "Elimination et disposition hepatique de la ticarcilline et de l'acide clavulanique etude expérimentale." Médecine et Maladies Infectieuses 18, no. 10 (1988): 452–57. http://dx.doi.org/10.1016/s0399-077x(88)80233-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Chastagner, P., L. Mougel, A. Lozniewski, et al. "Traitement des épisodes fébriles chez les enfants neutropéniques par l'association ticarcilline-acide clavulanique et nétilmicine." Médecine et Maladies Infectieuses 27, no. 3 (1997): 301–5. http://dx.doi.org/10.1016/s0399-077x(97)80170-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Laporte, J. P., A. Verny, N. C. Gorin, A. Najman, and G. Duhamel. "Traitement par ticarcilline-acide clavulanique (TIC-CLA) et amikacine (AMK) utilisés en premiere intention en hématologie." Médecine et Maladies Infectieuses 15, no. 5 (1985): 301. http://dx.doi.org/10.1016/s0399-077x(85)80132-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Herbrecht, R., Y. Piemont, J. P. Bergerat, et al. "Etude de l'Association ticarcilline/acide clavulanique plus netilmicine dans le traitement des infections chez les patients neutropeniques." Médecine et Maladies Infectieuses 17, no. 3 (1987): 117–20. http://dx.doi.org/10.1016/s0399-077x(87)80341-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Makanera, Abdoulaye, S. Sidibe, A. Camara, et al. "Diversité et sensibilité aux antibiotiques de différentes espèces de Pseudomonas à l'Hôpital de l'Amitié Sino-Guinéenne, Kipé/Conakry." Revue Malienne d'Infectiologie et de Microbiologie 14, no. 2 (2019): 14–21. http://dx.doi.org/10.53597/remim.v14i2.1364.

Full text

Abstract:

Introduction : Les infections à Pseudomonas constituent un réel problème de santé publique mondiale.L'objectif de cette étude était de déterminer les espèces de Pseudomonas isolées de diverses secrétionsbiologiques ainsi que leur sensibilité aux antibiotiques. Matériel et méthodes : Il s'agit d'une étuderétrospective réalisée à l'Hôpital de l'Amitié Sino-Guinéenne de Juin 2014 à Juin 2018. Les cultures ont étéfaites sur milieux gélosés. L'identification bactérienne, les antibiogrammes et la détermination desconcentrations minimales inhibitrices (CMI) ont été faites à l'automate Vitek2 Compact

APA, Harvard, Vancouver, ISO, and other styles

12

Roussel-Delvallez, M., M. Caillaux, C. Cattoen, et al. "Prévalence de la résistance d’Escherichia coli isolés de prélèvements urinaires (U) ou gastro-intestinaux (D) à l’association ticarcilline-acide clavulanique et aux autres antibiotiques." Antibiotiques 9, no. 4 (2007): 260–64. http://dx.doi.org/10.1016/s1294-5501(07)73923-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Wang, Moli, Yanxia Gao, Xueli Liu, et al. "Determination and pharmacokinetic analysis of ticarcillin disodium–clavulanate potassium for injection in rat plasma by UPLC-ESI-MS/MS." Journal of International Medical Research 48, no. 12 (2020): 030006052096782. http://dx.doi.org/10.1177/0300060520967822.

Full text

Abstract:

Objective To establish a specific and rapid ultra-high-performance liquid chromatography–electrospray ionization–tandem mass spectrometry (UPLC-ESI-MS/MS) method for measuring ticarcillin and clavulanate levels in rat plasma. Methods A Waters ACQUITY BEH C18 column (50 mm × 2.1 mm, 1.7 μm) and SCIEX QTRAP® LC-MS/MS System were used. Analyses were conducted to optimize the chromatographic and MS conditions, and the pharmacokinetic parameters of ticarcillin and clavulanate were assessed. Results Linear relationships were observed in the ranges of 10 to 10,000 ng/mL for ticarcillin R (r2 = 0.9967

APA, Harvard, Vancouver, ISO, and other styles

14

Dubé, L., M. A. Robaux, F. Oger, et al. "R058 Activite de la ticarcilline-acide Clavulanique (TCC) et de la Gentamicine (G) sur un modele d'endocardite experimentale du lapin due A Enterococcus faecalis (EF), avec simulation des pharmacocinetiques humaines." Annales Françaises d'Anesthésie et de Réanimation 17, no. 8 (1998): 841. http://dx.doi.org/10.1016/s0750-7658(98)80178-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Errecalde, J. O., C. E. Lanusse, O. N. Mestorino, M. F. Landoni, and A. L. Soraci. "Pharmacokinetics of Ticarcillin and Ticarcillin-Probenecid in Sheep." Journal of Veterinary Medicine Series A 38, no. 1-10 (1991): 255–60. http://dx.doi.org/10.1111/j.1439-0442.1991.tb01010.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

GELFAND, MICHAEL S., RONALD D. LAWSON, and WILLIAM BAUCOM. "Ticarcillin-Clavulanate Therapy for Infections With Ticarcillin-Resistant Microorganisms." Southern Medical Journal 82, no. 4 (1989): 433–37. http://dx.doi.org/10.1097/00007611-198904000-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Wright, Jennifer C., Carl N. Durham, and Jacob R. Dunbar. "Determination of Ticarcillin and Clavulanic Acid in Serum by Liquid Chromatography." Journal of AOAC INTERNATIONAL 75, no. 1 (1992): 30–33. http://dx.doi.org/10.1093/jaoac/75.1.30.

Full text

Abstract:

Abstract A liquid chromatographic (LC) method using solidphase extraction for the determination of clavulanic acid and ticarcillin in human serum has been developed. Clavulanic acid and ticarcillin were extracted separately from 1 mL serum using C18 solid-phase extraction cartridges. Eluates were analyzed by the same reversed-phase LC system. The overall mean recovery of clavulanic acid from serum was 99.7 ±2.3%; the lowest level validated in serum was 0.5 μg/mL. The overall mean recovery of ticarcillin from serum was 101.5 ±3%; the lowest level validated in serum was 12.5 μg/mL. Detection lim

APA, Harvard, Vancouver, ISO, and other styles

18

Lister, Philip D., Victoria M. Gardner, and Christine C. Sanders. "Clavulanate Induces Expression of the Pseudomonas aeruginosa AmpC Cephalosporinase at Physiologically Relevant Concentrations and Antagonizes the Antibacterial Activity of Ticarcillin." Antimicrobial Agents and Chemotherapy 43, no. 4 (1999): 882–89. http://dx.doi.org/10.1128/aac.43.4.882.

Full text

Abstract:

ABSTRACT Although previous studies have indicated that clavulanate may induce AmpC expression in isolates of Pseudomonas aeruginosa, the impact of this inducer activity on the antibacterial activity of ticarcillin at clinically relevant concentrations has not been investigated. Therefore, a study was designed to determine if the inducer activity of clavulanate was associated with in vitro antagonism of ticarcillin at pharmacokinetically relevant concentrations. By the disk approximation methodology, clavulanate induction of AmpC expression was observed with 8 of 10 clinical isolates of P. aeru

APA, Harvard, Vancouver, ISO, and other styles

19

&NA;. "Clavulanic acid/ticarcillin." Reactions Weekly &NA;, no. 553 (1995): 4. http://dx.doi.org/10.2165/00128415-199505530-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

&NA;. "Ticarcillin/clavulanic acid." Reactions Weekly &NA;, no. 391 (1992): 12. http://dx.doi.org/10.2165/00128415-199203910-00028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Reed, Michael D. "Rational Prescribing of Extended-Spectrum Penicillin β-Lactamase Inhibitor Combinations: Focus on Ticarcillin/Clavulanic Acid". Annals of Pharmacotherapy 32, № 1 (1998): S17—S21. http://dx.doi.org/10.1177/106002809803200105.

Full text

Abstract:

OBJECTIVE To provide an overview of the clinical pharmacokinetics and pharmacodynamics of ticarcillin/clavulanic acid and to reassess traditional dosage recommendations based on contemporary pharmacokinetic and pharmacodynamic principles. DATA SOURCES Published ticarcillin and clavulanic acid pharmacokinetic data derived from infants and children combined with data obtained from a rigorous, dose-escalation study performed in 12 healthy adults. Pharmacodynamic correlates were derived from published in vitro susceptibility data for the combination drug ticarcillin/clavulanic acid. DATA SYNTHESIS

APA, Harvard, Vancouver, ISO, and other styles

22

Mopper, Barry. "Liquid Chromatographic Determination of Carhenicillin and Ticarcillin in Injectable Dosage Forms." Journal of AOAC INTERNATIONAL 71, no. 2 (1988): 390–93. http://dx.doi.org/10.1093/jaoac/71.2.390.

Full text

Abstract:

Abstract A reverse-phase liquid chromatographic method is described for the assay of carbenicillin and ticarcillin in injectable dosage forms. These penicillins were analyzed isocratically on an octadecyl silane column using a mobile phase consisting of acetonitrile-O.OlM potassium phosphate monobasic (12 + 88, v/v) with photometric detection at 225 nm. Propylthiouracil was used as an internal standard. Detector responses were rectilinearly related to concentrations of carbenicillin and ticarcillin in the ranges 40 to 130 ug/mL (r = 0.5987) and 20 to 90 fig/mL (r = 0.9998), respectively. Using

APA, Harvard, Vancouver, ISO, and other styles

23

&NA;. "Ticarcillin/clavulanic acid overdose." Reactions Weekly &NA;, no. 1004 (2004): 14–15. http://dx.doi.org/10.2165/00128415-200410040-00043.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

&NA;. "Ticarcillin-clavulanic acid/vancomycin." Reactions Weekly &NA;, no. 681 (1997): 12. http://dx.doi.org/10.2165/00128415-199706810-00032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

McIntire, Lynn C., and Maria C. Castano. "Ticarcillin/Clavulanate Desensitization Protocol." Annals of Pharmacotherapy 28, no. 10 (1994): 1200. http://dx.doi.org/10.1177/106002809402801017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Kristjansson, Kristleifur, Frederick Cox, and Luann Taylor. "Ticarcillin/Clavulanic Acid Combination." Clinical Pediatrics 28, no. 11 (1989): 521–24. http://dx.doi.org/10.1177/000992288902801106.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

KASAI, TAKAO, TAKESHI NISHINO, YUZO KAZUNO, and TERUO TANINO. "THE ANTIBACTERIAL ACTIVITY OF TICARCILLIN/CLAVULANIC ACID (BRL28500) AGAINST TICARCILLIN-RESISTANT BACTERIA." Journal of Antibiotics 39, no. 10 (1986): 1450–60. http://dx.doi.org/10.7164/antibiotics.39.1450.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Fuchs, P. C., R. N. Jones, and A. L. Barry. "Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid." Journal of Clinical Microbiology 27, no. 11 (1989): 2475–81. http://dx.doi.org/10.1128/jcm.27.11.2475-2481.1989.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

MIKI, Fumio, Yoshiyasu IKUNO, Eiji INOUE, et al. "Comparative Study of BRL 28500 (Clavulanic Acid-Ticarcilin) and Ticarcillin in the Treatment of Respiratory Tract Infections." Journal of the Japanese Association for Infectious Diseases 61, no. 8 (1987): 944–79. http://dx.doi.org/10.11150/kansenshogakuzasshi1970.61.944.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Snydman, D. R., N. V. Jacobus, L. A. McDermott, et al. "Multicenter Study of In Vitro Susceptibility of theBacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996." Antimicrobial Agents and Chemotherapy 43, no. 10 (1999): 2417–22. http://dx.doi.org/10.1128/aac.43.10.2417.

Full text

Abstract:

ABSTRACT Antimicrobial resistance, including plasmid-mediated resistance, among the species of the Bacteroides fragilis group is well documented. An analysis of the in vitro susceptibility of B. fragilis group species referred between 1995 and 1996 as well as during a 7-year (1990 to 1996), prospective, multicenter survey of over 4,000 clinical isolates of B. fragilis group species was undertaken to review trends in the percent resistance to and geometric mean MICs of the antibiotics tested. There was a trend toward a decrease in the geometric mean MICs of most β-lactam antibiotics, while the

APA, Harvard, Vancouver, ISO, and other styles

31

Khdair, Saba R. "Detection of blaCTX-M gene among Pseudomonas aeruginosa isolated from water samples in Baghdad." Al-Mustansiriyah Journal of Science 28, no. 1 (2017): 35. http://dx.doi.org/10.23851/mjs.v28i1.309.

Full text

Abstract:

A total of 50 environmental Pseudomonas aeruginosa isolates were collected from sewage and tap water in Baghdad, Iraq. The MICs of Cefotaxime and Ceftazidime were determined by using agar dilution method, The MIC ranged from 2 to 256 µg/ml.The results of antibiotic sensitivity test showed that among sewage P. aeruginosa isolates, resistance was observed most often to Ticarcillin (92%), Penicillin G (84%), Ceftazidime (12%), (8%) for each of Cefotaxime and Ticarcillin. On the other hand, all tap water isolates were sensitive to Ofloxacin and Levofloxacin, Except (5%) of isolates were resistant

APA, Harvard, Vancouver, ISO, and other styles

32

Mandl, Delbert L., Mark W. Garrison, and Samuel D. Palpant. "Agranulocytosis Induced by Vancomycin or Ticarcillin/Clavulanate." Annals of Pharmacotherapy 31, no. 11 (1997): 1321–24. http://dx.doi.org/10.1177/106002809703101109.

Full text

Abstract:

OBJECTIVE: To reacquaint clinicians with a reportedly rare adverse event of agranulocytosis occurring after long-term administration of vancomycin and ticarcillin/clavulanate, with a subsequent review of other reported cases in the literature. CASE SUMMARY: A 45-year-old white woman with spina bifida developed agranulocytosis (2.7 × 103/mm3 white blood cells with only 3% polymorphonuclear leukocytes and no reported eosinophils or basophils) after long-term administration of vancomycin and ticarcillin/clavulanate for decubitus ulcers and chronic osteomyelitis. Consequently, the cell counts rebo

APA, Harvard, Vancouver, ISO, and other styles

33

Seldon, M. R., Barbara Bain, Carole A. Johnson, and C. S. Lennox. "Ticarcillin-Induced Immune Haemolytic Anaemia." Scandinavian Journal of Haematology 28, no. 5 (2009): 459–60. http://dx.doi.org/10.1111/j.1600-0609.1982.tb00553.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Teresi, Mary, and Jill Allison. "Interaction between vancomycin and ticarcillin." American Journal of Health-System Pharmacy 42, no. 11 (1985): 2420–22. http://dx.doi.org/10.1093/ajhp/42.11.2420.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Heigle, Thomas J., and Gholam A. Peyman. "Retinal Toxicity of Intravitreal Ticarcillin." Ophthalmic Surgery, Lasers and Imaging Retina 21, no. 8 (1990): 563–65. http://dx.doi.org/10.3928/1542-8877-19900801-09.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Hoellman, Dianne B., Melissa A. Visalli, Michael R. Jacobs та Peter C. Appelbaum. "Activities and Time-Kill Studies of Selected Penicillins, β-Lactamase Inhibitor Combinations, and Glycopeptides against Enterococcus faecalis". Antimicrobial Agents and Chemotherapy 42, № 4 (1998): 857–61. http://dx.doi.org/10.1128/aac.42.4.857.

Full text

Abstract:

ABSTRACT The activities of piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, vancomycin, and teicoplanin were tested against 212 Enterococcus faecalis strains (9 β-lactamase producers) by standard agar dilution MIC testing (104 CFU/spot). The MICs at which 50 and 90% of the isolates were inhibited (MIC50s and MIC90s, respectively) were as follows (μg/ml): piperacillin, 4 and 8; piperacillin-tazobactam, 4 and 8; ticarcillin, 64 and 128; ticarcillin-clavulanate, 64 and 128; ampicillin, 2 and 2; ampicillin-sulbactam, 1 and 2; vancomycin

APA, Harvard, Vancouver, ISO, and other styles

37

Owens, R. C., M. A. Banevicius, D. P. Nicolau, C. H. Nightingale, and R. Quintiliani. "In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates." Antimicrobial Agents and Chemotherapy 41, no. 11 (1997): 2586–88. http://dx.doi.org/10.1128/aac.41.11.2586.

Full text

Abstract:

The microdilution checkerboard technique was utilized to distinguish synergistic activity between tobramycin and four beta-lactams: piperacillin-tazobactam, ticarcillin-clavulanate, ceftazidime, and ceftriaxone. Beta-lactam-aminoglycoside combinations were tested against 75 clinical isolates of Pseudomonas aeruginosa, Acinetobacter baumanii, Citrobacterfreundii, Serratia marcescens, and Enterobacter cloacae. Despite in vitro susceptibilities, all isolates demonstrated either synergism or indifference; no antagonism was observed. Against pathogenic gram-negative nosocomial isolates, a greater p

APA, Harvard, Vancouver, ISO, and other styles

38

Muñoz Bellido, J. L., S. Muñoz Criado, I. García García, M. A. Alonso Manzanares, M. N. Gutiérrez Zufiaurre, and J. A. García-Rodríguez. "In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity." Antimicrobial Agents and Chemotherapy 41, no. 12 (1997): 2612–15. http://dx.doi.org/10.1128/aac.41.12.2612.

Full text

Abstract:

The activities of ampicillin, ampicillin-sulbactam, amoxicillin, amoxicillin-clavulanic acid, ticarcillin, ticarcillin-clavulanic acid, piperacillin, piperacillin-tazobactam, aztreonam, and aztreonam-clavulanic against Stenotrophomonas maltophilia strains for which the MICs of penicillins and commercially available beta-lactam-beta-lactamase inhibitor combinations were higher than the breakpoints usually recommended for Pseudomonas aeruginosa in commercially available broth microdilution methods were tested by the agar diffusion, agar dilution, and broth microdilution methods. Time-kill curve

APA, Harvard, Vancouver, ISO, and other styles

39

Bennett, AB, PA Martin, SA Gottlieb, and M. Govendir. "In vitro susceptibilities of feline and canineEscherichia coliandPseudomonasspp. isolates to ticarcillin and ticarcillin-clavulanic acid." Australian Veterinary Journal 91, no. 5 (2013): 171–78. http://dx.doi.org/10.1111/avj.12044.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Verbist, L., and J. Verhaegen. "Susceptibility of ticarcillin-resistant Gram-negative bacilli to different combinations of ticarcillin and clavulanic acid." Journal of Antimicrobial Chemotherapy 17, suppl C (1986): 7–15. http://dx.doi.org/10.1093/jac/17.suppl_c.7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Barka, M. S., A. Cherif-Anntar, and I. Benamar. "Antimicrobial resistance patterns and transferable traits in Enterobacteriaceae isolates from poultry in Tlemcen, Algeria." African Journal of Clinical and Experimental Microbiology 22, no. 2 (2021): 196–203. http://dx.doi.org/10.4314/ajcem.v22i2.12.

Full text

Abstract:

Background: Antibiotics are overused in poultry industry, and this has resulted in the emergence of multidrug resistant (MDR) bacteria. The current study is aimed at determining antimicrobial resistance (AMR) patterns of Enterobacteriaceae isolates from poultry in the west of Algeria.Methodology: Different chicken samples (kidney, bone and intestine) were collected and processed for culture using standard microbiological methods to isolate Enterobacteriaceae. Isolates were identified biochemically using API 20E, while isolated Escherichia coli was typed for O1, O2 and O78 antigens using slide

APA, Harvard, Vancouver, ISO, and other styles

42

&NA;. "Sulbactam/ampicillin or ticarcillin/clavulanic acid?" Inpharma Weekly &NA;, no. 1196 (1999): 6. http://dx.doi.org/10.2165/00128413-199911960-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Poupard, J. A., and B. Wester. "Ticarcillin-clavulanic acid zone size criteria." Antimicrobial Agents and Chemotherapy 36, no. 10 (1992): 2352. http://dx.doi.org/10.1128/aac.36.10.2352.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Ryen, Jeremy, and Frank J. Dudley. "Cholestasis with ticarcillin‐potassium clavulanate (Timentin)." Medical Journal of Australia 156, no. 4 (1992): 291. http://dx.doi.org/10.5694/j.1326-5377.1992.tb139759.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Gilbar, Peter, and Zoe McAllan. "Ticarcillin-Potassium Clavulanate and Vancomycin Incompatibility." Australian Journal of Hospital Pharmacy 27, no. 6 (1997): 470. http://dx.doi.org/10.1002/jppr1997276470.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Tasker, T. C. G., A. Cockburn, D. Jackson, G. Mellows, and D. White. "Safety of ticarcillin disodium/potassium clavulanate." Journal of Antimicrobial Chemotherapy 17, suppl C (1986): 225–32. http://dx.doi.org/10.1093/jac/17.suppl_c.225.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Meier, H., D. Adam, and H. D. Heilmann. "Penetration of ticarcillin/clavolanate into cartilage." Journal of Antimicrobial Chemotherapy 24, suppl B (1989): 101–5. http://dx.doi.org/10.1093/jac/24.suppl_b.101.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Feld, Ronald. "A Multicenter Comparative Trial of Tobramycin and Ticarcillin vs Moxalactam and Ticarcillin in Febrile Neutropenic Patients." Archives of Internal Medicine 145, no. 6 (1985): 1083. http://dx.doi.org/10.1001/archinte.1985.00360060149023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Feld, R. "A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients." Archives of Internal Medicine 145, no. 6 (1985): 1083–88. http://dx.doi.org/10.1001/archinte.145.6.1083.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Sanders, C. C., and S. J. Cavalieri. "Relevant breakpoints for ticarcillin-clavulanic acid should be set primarily with data from ticarcillin-resistant strains." Journal of Clinical Microbiology 28, no. 4 (1990): 830–31. http://dx.doi.org/10.1128/jcm.28.4.830-831.1990.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!